Abstract
The orexin (hypocretin) neurotransmitter system was recently shown to be directly involved in the pathogenesis of narcolepsy in two animal models. Furthermore, decreased levels of orexin A in the CSF were shown in narcoleptic patients. To define any genetic contribution of orexin to the etiology of narcolepsy, the authors screened the entire prepro-orexin gene for mutations or polymorphisms in 133 patients suffering from narcolepsy. They report an association of a rare polymorphism in the prepro-orexin gene with narcolepsy in a cohort of 178 patients.
| Original language | English |
|---|---|
| Journal | Neurology |
| Volume | 56 |
| Issue number | 1 |
| Pages (from-to) | 115-117 |
| Number of pages | 3 |
| ISSN | 0028-3878 |
| DOIs | |
| Publication status | Published - 09.01.2001 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 10 Reduced Inequalities
Fingerprint
Dive into the research topics of 'A prepro-orexin gene polymorphism is associated with narcolepsy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver